New Study Supporting The Pivotal Role Of Tumor Grade In Chemotherapy Prescription At The 32nd Annual San Antonio Breast Cancer Symposium
December 28, 2009 by · Leave a Comment
Ipsogen SA (Alternext: ALIPS) today announced that a new study confirming the pivotal role of tumor grade in chemotherapy prescription has been presented at the 32nd Annual San Antonio Breast Cancer Symposium (SABCS), December 9-13, 2009. The study was conducted at Institut Paoli Calmettes (IPC) Cancer Centre, Marseille, France…
Women's Health Policy Report Highlights Studies From Recent Breast Cancer Conference
December 17, 2009 by · Leave a Comment
The following summarizes findings reported last week at the San Antonio Breast Cancer Symposium. ~ Anthracyclines: New research suggests that anthracyclines — a class of chemotherapy drugs commonly used to treat breast cancer — could cause more harm than benefits for breast cancer patients because they can be damaging to the heart, the Wall Street Journal reports…



















































